Derivation and validation of a risk classification tree for patients with synovial sarcoma

BACKGROUND: Synovial sarcoma (SS) accounts for 8%–10% of all soft‐tissue sarcomas. Clinical presentation and outcomes vary, yet discrete risk groups based on validated prognostic indices are not defined for the full spectrum of patients with SS. METHODS: We performed a retrospective cohort study usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Neel, Dylan V., Ma, Clement, Collins, Natalie B., Hornick, Jason L., Demetri, George D., Shulman, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844650/
https://www.ncbi.nlm.nih.gov/pubmed/35670308
http://dx.doi.org/10.1002/cam4.4909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844650/
https://www.ncbi.nlm.nih.gov/pubmed/35670308
http://dx.doi.org/10.1002/cam4.4909

Ejemplares similares